Lumira Ventures — 2019 Investments
2 investments dated 2019 · listed companies and verified rows first · show all
Exact Imaging develops the ExactVu micro-ultrasound platform, a 29 MHz imaging system that lets urologists perform real-time targeted and systematic prostate biopsies within a standard workflow.
HardwareHealthtechMedical DevicesMarkham, CA
Randy AuCoin(President & CEO)William Wortman(Director)Rob Sandler(Executive Officer)Harold Wodlinger(Director)Jerrold Wen(Executive Officer)Diane Lejeune(Director)
Board seatPeter van der Velden· per SEC Form D
Co-investorsiGan PartnersPMVVenture OntarioVesalius Biocapital Partners
HistoSonics develops histotripsy technology, a non-invasive method that uses focused sound energy to destroy targeted tissue, offered as a medical device for physicians and their patients.
BiotechHardwareHealthtechMedical DevicesAnn Arbor, GB
Thomas Davison(Executive Officer, Director)M. Christine Gibbons(Executive Officer, Director)Wen Chen(Director)Tom Tefft(Director)Michael Blue(Executive Officer, Director)Fred Lee(Director)
Board seatGerry Brunk· per SEC Form D
Co-investorsAlpha Wave GlobalAmzak HealthEarly Stage Partners, LPHealthQuest CapitalMichigan Capital NetworkBezos Expeditions+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.